JenaValve Technology

Developing transcatheter heart valve systems for aortic disease treatment.

Founded 2006 · 195 employees · United States · Private

Funding:

Series C · $8M · 2024

Subsidiaries:

JenaValve Technology GmbH, JenaValve Production Ltd